14
Participants
Start Date
May 20, 2025
Primary Completion Date
July 12, 2025
Study Completion Date
July 12, 2025
balcinrenone/ dapagliflozin
Participants will be receiving balcinrenone/ dapagliflozine in fasted or fed condition.
quinidine
Participants will be receiving quinidine orally in fasted condition.
Research Site, Harrow
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY